Eisai cuts ribbon on new US headquarters in Nutley

Eisai Inc. held the official grand opening of its new headquarters Aug. 18, the Eisai US hhceco Center in Nutley.

The new 15-story, 332,800-square-foot space facility is part of the ON3 Campus. The pharmaceutical company says the facility is strategically located to advance its human health care (hhc) mission, featuring collaborative relationships to further its work addressing people’s needs. The Eisai US hhceco Center continues the company’s commitment to addressing pressing medical challenges in cancer, Alzheimer’s disease and other neurological diseases.

The ribbon cutting featured a number of lawmakers, executives, stakeholders and dignitaries, including Gov. Phil Murphy and Lt. Gov. Sheila Oliver.

“We’re excited to welcome the new Eisai hhceco Center to our very own Nutley, N.J.,” said Murphy. “This new collaborative and innovative center will bring hundreds of jobs to our state.”

The company estimates that the facility will bring 800 jobs to the Nutley-Clifton area, and at full capacity, will accommodate 1,300 employees.

The space is designed as a hybrid working model to foster flexibility across the organization. It features a dedicated space and resources to educate and motivate team members, an expansive cafeteria, café bars, huddle spaces and an auditorium—all designed to provide employees with the ability to collaborate, innovate and grow as part of the Eisai organization.

“The official grand opening of the Eisai hhceco Center reinforces our 30-year commitment to New Jersey and signifies the beginning of a new chapter as we establish an ecosystem platform to collaborate with industry, government, medical organizations and the community to deliver breakthrough medicines and new solutions that alleviate the health concerns of people so they can live healthier and more fulfilling lives,” said Ivan Cheung, chairman and CEO of Eisai Inc.; global Alzheimer’s disease officer; and senior corporate officer, Eisai Co. Ltd.

The ON3 Campus also includes Hackensack Meridian School of Medicine, Seton Hall College of Nursing and School of Health and Medicine Sciences, Quest Diagnostics, and Hackensack Meridian Center for Discovery and Innovation, which when combined with Eisai’s research and development work, sets the stage for a lot of potential innovation in the decades ahead.

“We are thrilled to have Eisai’s U.S. Headquarters here in New Jersey and in this hub of innovation,” said Robert Garrett, CEO, Hackensack Meridian Health. “This campus is at the heart of Hackensack Meridian Health’s strategy to build the health system for the future. Our School of Medicine and the Center for Discovery and Innovation are foundational to our mission, to transform health care and to be the leader of positive change.”

“New Jersey has become a hub for innovation in many industries, and Eisai’s extraordinary innovative research that will take place here will contribute to life-changing scientific and medical solutions for people living with cancer, Alzheimer’s disease and other neurodegenerative diseases,” said Murphy.

“We are so honored to celebrate this important milestone for our company with such an esteemed group of dignitaries and contributors to the New Jersey life sciences community,” said Cheung.